Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04782024
Other study ID # 15KMHI
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date September 30, 2015
Est. completion date November 4, 2016

Study information

Verified date April 2021
Source KGK Science Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will investigate the effect of two different doses of 7-Keto compared to placebo on resting metabolic rate. One third of subjects will be given the lower 7-Keto dose, one third will be given the higher 7-Keto dose and one third will be given the placebo.


Recruitment information / eligibility

Status Completed
Enrollment 138
Est. completion date November 4, 2016
Est. primary completion date November 4, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 55 Years
Eligibility Inclusion Criteria: 1. Male or female 20 to 55 years of age 2. If female, subject is not of child bearing potential. Defined as females who have had a hysterectomy or oophorectomy, bilateral tubal ligation or are post-menopausal (natural or surgically with > 1 year since last menstruation). OR Female subject of childbearing potential must agree to use a medically approved method of non-hormonal birth control and have a negative urine pregnancy test result. Birth Control methods must be initiated at least 14 days prior to randomization and must be continued until 28 days after the end of study visit. Acceptable methods of birth control include: - Double barrier method - Intrauterine devices (non-hormonal) - Cervical caps or sponges - Use of male/female condom - Vasectomy of partner - Non-heterosexual lifestyle 3. If female and currently experiencing menstrual cycles, subjects should have regular menstrual cycles (28 ± 2 days) and must be in their follicular phase during the duration of the study period (i.e. baseline to visit 3) 4. BMI 25-34.9 ±1 kg/m2 5. Stable weight defined as less than 5kg (approx. 11lbs) gained or lost in the past 3 months 6. Sedentary subjects; defined as subjects with a desk/inactive job, not engaging in any regular sports or exercise programs either at an exercise facility or at home. Occasional activity, low intensity yoga and walking at a regular pace are acceptable. 7. Agreement to maintain current level of physical activity through the study and avoid exercising 24 hours prior to study visits 8. Agreement to adopt a diet with a 500 kcal reduction for the duration of the study period. 9. Agreement to completely avoid caffeine consumption, such as coffee, tea and soft drinks 24 hours before study visits and to limit consumption of coffee, tea and soft drinks to 2 cups per day for all other days during the study. 10. Agreement to completely avoid consumption of energy drinks for 24 hours before the screening and baseline visits and for the duration of the study. 11. Has given voluntary, written, informed consent to participate in the study Exclusion Criteria: 1. Women who are pregnant, breastfeeding, or planning to become pregnant during the course of the trial 2. Immunodeficiency (i.e. HIV positive, rheumatoid arthritis, history of organ transplant) 3. Use of tobacco products and nicotine products. 4. Use of prescription, over-the-counter, or natural health products known to affect weight and/or metabolic rate within 4 weeks of randomization and during the trial 5. Unstable medical conditions 6. Uncontrolled blood pressure (i.e. systolic blood pressure > 160 mmHg or diastolic blood pressure > 100 mmHg) 7. Type I or II diabetes, metabolic disease or any condition that in the opinion of the Qualified Investigator does not safely allow for a reduction in calorie intake 8. Any evidence of an eating disorder, such as anorexia or bulimia, or the presence of any illness that might represent a potential cause of weight loss 9. Abnormal ECG at screening 10. Clinically significant abnormal laboratory results at screening (e.g. AST and/or ALT > 2 x ULN, and/or bilirubin > 2 x ULN; serum creatinine > 1.5 x ULN) 11. Currently taking anti-psychotic medication 12. Participation in a clinical research trial within 30 days prior to randomization 13. Allergy or sensitivity to study supplement ingredients 14. Alcohol abuse (>2 standard alcoholic drinks per day) 15. Current drug abuse or drug abuse within the past 6 months 16. Use of marijuana for medical purposes 17. Individuals who are cognitively impaired and/or who are unable to give informed consent 18. Any other condition, which in the Investigator's opinion, may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
7-Keto 50mg

7-Keto 25mg

Placebo


Locations

Country Name City State
United States KGK USA Foothill Ranch California
United States KGK USA Orlando Florida

Sponsors (2)

Lead Sponsor Collaborator
KGK Science Inc. InterHealth Nutraceuticals, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Number of incidents of abnormal lab results Lab results from blood biochemistry and hematology (Na, K, Cl, creatinine, BUN, AST, ALT, GGT and bilirubin) 1 week: from baseline to end of study
Other Number of incidents of adverse events 1 week: from baseline to end of study
Other Change in BMI 1 week: from baseline to end of study
Primary Change in resting metabolic rate 1 week: from baseline to end of study
Secondary Change in total body water 1 week: from baseline to end of study
Secondary Change in total body fat 1 week: from baseline to end of study
See also
  Status Clinical Trial Phase
Completed NCT03007459 - The Health of Competitive Fitness Athletes
Completed NCT00502931 - A Systematic Review on the Accuracy and Reliability the BodyGem/MedGem Metabolic Devices N/A
Completed NCT05412511 - Metabolic Cost of Medicine Ball Training N/A
Completed NCT05412498 - Metabolic Cost of Battle Rope Training N/A
Completed NCT02022176 - Modulation of Metabolic Rate by Inorganic Nitrate N/A
Completed NCT04478565 - Development of Alternatives for the Estimation of the Resting Metabolic Rate From Anthropometry in Paralympic Athletes
Completed NCT03134781 - Hybrid Exercise Training for Weight Loss N/A
Completed NCT05221177 - Metabolic Cost of Suspension Exercise Training (SET-UTH) N/A
Completed NCT05221203 - Metabolic Cost of Bodyweight Training N/A
Completed NCT03035903 - Energy Cost for Holding a MedGem® Indirect Calorimeter N/A
Not yet recruiting NCT06107959 - Changes in Resting Metabolic Rate Following Orthopedic Surgery
Completed NCT04151927 - Effects of Overnight Low Oxygen Exposure on Energy Balance N/A